Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Brand Names (Mounjaro & Zepbound): Mounjaro is FDA-approved for managing type 2 diabetes Zepbound is FDA-approved specifically for chronic weight management Typical cost: $1,000-$1,400 per month without insurance Often subject to supply shortages and insurance restrictions Compounded Tirzepatide (What We Primarily Use): Same active ingredient, compounded by licensed pharmacies More affordable: typically $300-$500 per month More readily available without supply chain issues Allows for flexible dosing tailored to your needs At Peak Performance, we primarily prescribe compounded Tirzepatide because it offers the same clinical results at a more accessible price point
Obesity Research & Clinical Practice, 9(3), 301-304
The study is continuing for another 168 weeks to assess long-term effects
Data Bridge Market Research is a leader in advanced formative research
